AHPA has created this Web Center to provide its members with information on the novel coronavirus and COVID-19 pandemic as well as possible impacts on the herbal products industry. AHPA intends to update the WebCenter on a timely basis as new information becomes available. However, especially given the quickly evolving nature of these issues, AHPA cannot guarantee the completeness, currentness, or accuracy of information included on or linked from the WebCenter. AHPA recommends that members use the WebCenter as just one resource for relevant information on these issues and, as needed, consult their own legal and regulatory experts.
The CDC has issued updated recommendations on the distribution of the new COVID-19 vaccines. However, state and municipal health departments have ultimate authority over how vaccines are distributed. This site contains the most comprehensive, updated list of state by state vaccine distribution policies, as well as links to each state's health authority.
COVID-19 vaccine information
The CDC has released detailed information on how each vaccine should be administered.
Note that for the Pfizer and Moderna vaccines, CDC now advises a greater than two week time gap between shots. Note that vaccination distribution decisions can involve equal employment protection considerations. The EEOC has provided a set of resources for companies on these issues. AHPA is preparing additional resources to help its members navigate vaccine distribution issues.
The CDC states that COVID-19 is thought to spread primarily between people who are in close contact (within about 6 feet) through respiratory droplets produced when an infected person coughs or sneezes. These droplets can transmit the virus when they are absorbed through the mouth or nose, or inhaled into the lungs. It may be possible that COVID-19 can be transmitted by touching a surface or object that has the virus on it and then touching their own mouth, nose, or possibly their eyes, but this is not thought to be the main way the virus spreads.
Low risk of transmission through food and packaging
FDA has stated that it is “not aware of any reports at this time of human illnesses that suggest COVID-19 can be transmitted by food or food packaging.” FDA recommends everyone "follow the 4 key steps of food safety - clean, separate, cook, and chill." CDC states that there is low risk of spreading the virus from products or packaging that are shipped over a period of days or weeks at ambient temperatures. However, "if you are concerned about contamination of food or food packaging, wash your hands after handling food packaging, after removing food from the packaging, before you prepare food for eating, and before you eat", according to FDA. CDC has provided guidelines on frequent hand washing with soap and water for at least 20 seconds and frequently clean and disinfect surfaces. The Food Industry Association (FMI) has additional information on the COVID-19, including information from the CDC that products and packages shipped to the U.S. from China pose a very low risk of spreading the virus as COVID-19 is most likely to be spread via respiratory droplets.
The FDA has provided a roadmap of its plans to resume inspection activity based on ongoing risk evaluations. As in the past, this is subject to an advisory risk system based on the prevalence of COVID-19 in each state.
FDA resumes some domestic inspections, provides AER flexibility
The FDA has provided guidance with recommendations to industry regarding postmarketing adverse event reporting for drugs, biologics, medical devices, combination products, and dietary supplements during a pandemic.
The CDC has an active resource guide for business. The CDC stresses that employers must consider how to decrease the spread of any illness in order to lower the impact in their workplace in the event of an outbreak. Employers should consider how to:
Businesses practices to mitigate the impact
- reduce transmission among staff;
- protect those at higher risk for adverse health complications;
- maintain business operations; and
- minimize adverse effects on other entities in their supply chains.
The U.S. Occupational Health and Safety Administration (OSHA) provides resources to help companies protect workers during a pandemic.
Crowded travel settings, like airports, may increase chances of getting COVID-19, if there are other travelers with COVID-19 infection. CDC provides recommendations for international travel, including guidance on when to consider postponing or canceling travel. The U.S. and Canada mutually agreed to temporarily close the border and the U.S. has barred the entry of all foreign nationals who had visited China, Iran and a group of European countries during the previous 14 days. All Americans who have been in high-risk areas and return to the U.S. are required to fly to one of 13 airports. The U.S. State Department provides travel information for U.S. citizens and maintains a list of travel advisories (sortable by date and country) from around the world.